Globe Life (NYSE:GL) Issues FY 2027 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY 2027 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 16.100-17.100 for the period, compared to the consensus estimate of 16.510. Globe Life also updated its FY 2026 guidance to 15.350-15.650 EPS.

Globe Life Trading Down 8.2%

NYSE GL opened at $154.62 on Friday. Globe Life has a fifty-two week low of $127.85 and a fifty-two week high of $191.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. The stock has a 50 day simple moving average of $169.95 and a two-hundred day simple moving average of $167.16. The stock has a market cap of $11.88 billion, a P/E ratio of 10.34 and a beta of 0.44.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, October 21st. The company reported $4.84 earnings per share for the quarter, missing analysts’ consensus estimates of $4.90 by ($0.06). Globe Life had a return on equity of 19.95% and a net margin of 18.89%. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the business posted $4.81 earnings per share. Globe Life’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, analysts forecast that Globe Life will post 15.61 earnings per share for the current year.

Globe Life Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be issued a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life’s payout ratio is 8.83%.

Globe Life announced that its board has authorized a stock repurchase plan on Monday, August 10th that authorizes the company to buy back $2.50 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 17.7% of its shares through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.

Wall Street Analyst Weigh In

GL has been the topic of a number of research analyst reports. TD Cowen reduced their price objective on shares of Globe Life from $225.00 to $215.00 and set a “buy” rating on the stock in a research report on Friday. UBS Group set a $165.00 target price on shares of Globe Life in a research report on Friday. Piper Sandler cut shares of Globe Life from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $200.00 to $165.00 in a research report on Friday. Jefferies Financial Group lifted their target price on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Globe Life from $193.00 to $195.00 and gave the company an “overweight” rating in a research report on Thursday, October 15th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $182.60.

Insider Transactions at Globe Life

In related news, CEO James Darden sold 50,000 shares of Globe Life stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the sale, the chief executive officer directly owned 58,451 shares in the company, valued at $10,663,215.93. The trade was a 46.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Hensley sold 10,000 shares of the company’s stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $170.07, for a total value of $1,700,700.00. Following the completion of the sale, the executive vice president directly owned 12,384 shares in the company, valued at approximately $2,106,146.88. The trade was a 44.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 143,650 shares of company stock worth $25,793,717 over the last 90 days. 2.11% of the stock is currently owned by insiders.

Globe Life News Roundup

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life projected 2027 adjusted earnings of $16.10–$17.10 per share, with the midpoint modestly above the current consensus estimate of $16.51. Management also targeted $850 million–$950 million in parent excess cash flow, supporting potential capital returns. Globe Life projects 2027 EPS and excess cash flow
• Positive Sentiment: TD Cowen maintained a Buy rating, although it reduced its price target from $225 to $215. The revised target still implies substantial potential upside based on the referenced share price. TD Cowen price target update
• Neutral Sentiment: Management’s 2027 EPS guidance range spans $16.10–$17.10, indicating continued growth potential but also a relatively wide range of outcomes. The company’s quarterly revenue and investment income benefited from growth in premiums and investments. Globe Life earnings guidance
• Negative Sentiment: Globe Life reported third-quarter EPS of $4.84, below analyst expectations near $4.87–$4.90. Weaker underwriting income, rising expenses and a reported $6.4 million underwriting loss offset higher premiums and investment income. Globe Life Q3 earnings miss
• Negative Sentiment: Globe Life lowered its 2026 EPS guidance to $15.35–$15.65, below the $15.72 consensus estimate. The weaker outlook was linked in part to losses at Evry Health, increasing concerns about profitability and execution. Evry Health losses and Globe Life guidance
• Negative Sentiment: Piper Sandler downgraded Globe Life, arguing that the stock is no longer a “predictable safe haven” following the earnings release. The downgrade adds pressure to investor sentiment after the earnings miss and guidance reduction. Piper Sandler downgrades Globe Life

About Globe Life

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.